Ravindran Kanesvaran, Chairman of the Division of Medical Oncology at the National Cancer Centre Singapore, and Distinguished Professor of Geriatric Oncology at Duke-NUS Medical School, shared a post on LinkedIn:
“Yesterday we officially launched the Asia Pacific GU Cancer Consortium (APGUCC) in Singapore – the first dedicated GU cancers network of its kind in our region, bringing together experts from 10 Asian countries and over 15 sites, with more centres already signalling their interest to join.
APGUCC is built on five pillars: real-world data and informatics, translational research, clinical trial support and coordination, education for healthcare professionals, and strong patient advocacy partnerships. Our goal is simple: to create a connected APAC ecosystem that can generate practice-changing evidence and elevate standards of care for patients with advanced RCC, prostate, bladder and testicular cancers.
Our kick-off meeting at the Conrad Singapore was immediately followed by the APAC Oncology Summit in GU cancers – the consortium’s first formal activity, delivered in close collaboration with industry partners. This is just the beginning.”
Ravindran Kanesvaran/LinkedIn
More posts featuring Ravindran Kanesvaran on OncoDaily.